Month: <span>June 2024</span>

Home / 2024 / June
Post

Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma

Nathan L. Boyer, MD – Uniformed Services University of the Health Sciences DISCLOSURES March 04, 2022 The U.S. Food and Drug Administration (FDA) has approved the first-in-class biologic tezepelumab-ekko as an add-on maintenance treatment to standard therapy for severe asthma in adults and children aged 12 years and older. The approval is based on results...

Post

New Era? ‘Double Selective’ Antibiotic Spares the Microbiome

A new antibiotic uses a never-before-seen mechanism to deliver a direct hit on tough-to-treat infections while leaving beneficial microbes alone. The strategy could lead to a new class of antibiotics that attack dangerous bacteria in a powerful new way, overcoming current drug resistance while sparing the gut microbiome. “The biggest takeaway is the double-selective component,”...

Post

Home Phototherapy for Psoriasis: Encouraging New Data, Optimizing Access – biomed tech

Doug Brunk May 22, 2024 Supporters of home phototherapy for patients with plaque and guttate psoriasis had plenty to cheer about at the annual meeting of the American Academy of Dermatology (AAD) in March. There, Joel M. Gelfand, MD, professor of dermatology and epidemiology at the University of Pennsylvania in Philadelphia, presented results from the...

Post

Psoriasis Linked to Higher Incidence of MACE Despite Statin Use

Over a period of 5 years, the likelihood of major adverse cardiovascular events (MACE) in patients with psoriasis and dyslipidemia who were on statin therapy was 40% greater than that in non-psoriasis patients with dyslipidemia on statin therapy, even after adjusting for covariates, results from a large retrospective study showed. “It is well-established that psoriasis...

Post

New ‘FLiRT’ COVID Variants Could Be Driving an Uptick in Cases. Here’s How to Avoid Them

COVID numbers are low, but some evidence suggests they could be rising. Here’s how to protect yourself this summer, according to experts BY LAUREN J. YOUNG Allen J. Schaben/Los Angeles Times via Getty Images Editor’s Note (6/5/25): Today the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee unanimously voted in favor of...

Post

Patients With Hypersensitivity Pneumonitis Share What Keeps Them Up at Night

Adults with hypersensitivity pneumonitis (HP) expressed interest in more knowledge of prognosis, etiology, treatment, and living well with the disease, based on new survey data presented at the American Thoracic Society International Conference. HP is caused by environmental exposure and is often incurable, and patients are challenged with identifying and mitigating the exposure with limited...

Can losing your sense of smell predict heart failure?
Post

Can losing your sense of smell predict heart failure?

JUNE 10, 2024 by Laura Williamson, American Heart Association Credit: Pixabay/CC0 Public DomainLosing the ability to smell properly—a common sensory deficit as people age—may help predict or even contribute to the development of heart failure, new research suggests. The study, published in the Journal of the American Heart Association, adds to a growing body of...

Post

Experts develop nutritional recommendations for patients treated with anti-obesity medications

NEWS RELEASE 10-JUN-2024 Peer-Reviewed PublicationTHE OBESITY SOCIETY ROCKVILLE, Md.— Individuals treated with anti-obesity medications generally experience reduced appetite, which typically leads to reduced food intake. As a result, dietary quality becomes more important because nutritional needs must be met within the context of eating less. To improve this process, medical experts have developed a list...